Table 1. Admission characteristics of children in the two study groups.
Variable | SP | Placebo |
**N = 597 | **N = 598 | |
Age (months) | ||
(mean, SD) | 28.4 (18) | 28.7 (19) |
Sex (male) % | 52.3% | 52.1% |
Ethnic group | ||
Mandingo | 228(39%) | 227(38%) |
Wollof | 74 (13%) | 91 (15%) |
Fula | 98 (17%) | 96 (16%) |
Jola | 85 (14%) | 88 (15%) |
Others | 102 (17%) | 93 (16%) |
Recruitment centre | ||
RVTH | 160 (27%) | 166 (28%) |
MRC | 117 (20%) | 114 (19%) |
Brikama | 155 (26%) | 152 (26%) |
Essau | 124 (21%) | 126 (21%) |
Sibanor* | 36 (6%) | 36 (6%) |
Previous chloroquine treatment (%) | 62.4 | 60.6 |
Educational attainment of mother (years in school), (mean, SD) | 2.1 (5.7) | 2.0 (3.6) |
Resp rate/min (mean, SD) | 40.0 (13) | 39.3 (12) |
Mean haemoglobin g/dl (SD) | 5.1 (1.2) | 5.2 (.053) |
Temp °C (mean, SD) | 37.5 (0.91) | 37.56 (.88) |
Pulse rate/min (mean, SD) | 121 (21) | 120 (21) |
Splenomegaly (%) | 19.8 | 24.7 |
Hepatomegaly (%) | 26.7 | 27.2 |
Proportion with malaria parasitaemia | 62% | 61% |
Geometric mean density (95% CI) IQR | 17710 (136223, 23024) (0, 51000) | 15296 (11668, 20050) (0, 47600) |
Sleeps nightly under intact or impregnated net# | 20.7 | 15.3 |
*Recruitment only during year 2.
**Data missing for 2 and 3 subjects in the placebo and SP groups respectively.
#bednet use was determined at the end of the transmission season.